The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Characterization of the porous structure of sba-15
Kruk, M., Jaroniec, M., Ko, C. H., & Ryoo, R. (2000) · Chemistry of Materials · doi:10.1021/cm000164e · Cited by 1,409
Cited by
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
Tang, F., Li, L., & Chen, D. (2012) · Advanced Materials · doi:10.1002/adma.201104763 · Cited by 2,836
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Mesoporous silica nanoparticles in drug delivery and biomedical applications
Wang, Y., Zhao, Q., Han, N., Bai, L., Li, J., Liu, J., Che, E., Hu, L., Zhang, Q., Jiang, T., et al. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.09.014 · Cited by 1,192
Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?
Brouwers, J., Brewster, M. E., & Augustijns, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21650 · Cited by 947
Self-citationFadeel, B., & Garcia-Bennett, A. E. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.008 · Cited by 783
Kunzmann, A., Andersson, B., Thurnherr, T., Krug, H., Scheynius, A., & Fadeel, B. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.04.007 · Cited by 527
Emerging trends in the stabilization of amorphous drugs
Laitinen, R., Löbmann, K., Strachan, C. J., Grohganz, H., & Rades, T. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.066 · Cited by 470
Li, Z., Zhang, Y., & Feng, N. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1575806 · Cited by 321
Biocompatibility of Mesoporous Silica Nanoparticles?
Shi, Y., Miller, M. L., & Di Pasqua, A. J. (2016) · Comments on Inorganic Chemistry · doi:10.1080/02603594.2015.1088439 · Cited by 315
Maleki, A., Kettiger, H., Schoubben, A., Rosenholm, J. M., Ambrogi, V., & Hamidi, M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.047 · Cited by 281
Speybroeck, M. V., Barillaro, V., Thi, T. D., Mellaerts, R., Martens, J., Humbeeck, J. V., Vermant, J., Annaert, P., Den Mooter, G. V., & Augustijns, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21638 · Cited by 270
Self-citationRosenholm, J. M., Mamaeva, V., Sahlgren, C., & Lindén, M. (2012) · Nanomedicine · doi:10.2217/nnm.11.166 · Cited by 263
Mellaerts, R., Jammaer, J. A. G., Van Speybroeck, M., Chen, H., Humbeeck, J. V., Augustijns, P., Van den Mooter, G., & Martens, J. A. (2008) · Langmuir · doi:10.1021/la801161g · Cited by 259
Self-citationE.A. AbouAitah, K., & A. Farghali, A. (2016) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000360 · Cited by 49
Sardana, K., Khurana, A., & Gupta, A. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1604218 · Cited by 28
Metadata
- Authors
- Mellaerts, R., Mols, R., Jammaer, J. A. G., Aerts, C. A., Annaert, P., Van Humbeeck, J., Van den Mooter, G., Augustijns, P., & Martens, J. A.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 69
- Issue
- 1
- Pages
- 223-230
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2071913543
- Cited by
- 244
- References
- 2
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.